Skip to main content
FTRE logo

FTRE · Fortrea Holdings Inc.

Track FTRE — free
Market Cap
$1.68B
Shares
95.10M

FTRE metrics

70 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.70
Market cap
$1.68B

Price action

19 metrics
Price change (1W)
-5.9%
Price change (30D)
-4.0%
Price change (3M)
+10.1%
Price change (6M)
+84.2%
Price change (YTD)
+2.6%
Price change (1Y)
+68.4%
Trailing year
Price change (5Y)
52-week high
$20.70
52-week low
$8.40
Change from 52-week high
-14.5%
Change from 52-week low
+110.7%
Annualized volatility
74.7%
Beta
2.1
RSI (14D)
45.3
Price vs SMA 50
-3.2%
Price vs SMA 200
+21.1%
Avg volume (3M)
1.39M
Relative volume
0.6
Average dollar volume
$25.06M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
95.10M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
1.0×
reciprocal yield 104.2%
EV / EBITDA
38.1×
reciprocal yield 2.6%
EV / EBIT
P / sales
0.6×
reciprocal yield 159.0%
P / book
3.2
reciprocal yield 31.1%
FCF yield
11.6%
TTM · current market cap
Buyback yield
P / FCF
8.6
reciprocal yield 11.6%
P / operating cash flow
7.4
reciprocal yield 13.5%
Earnings yield
-5.1%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
0.9×
reciprocal yield 105.8%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 105.8%
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
Operating margin
-0.4%
Trailing 12 months
Net margin
-3.2%
Gross profit (TTM)
Operating profit (TTM)
−$10.80M
Net income (TTM)
−$85.20M
Trailing 12 months
Diluted EPS (TTM)
$-0.81
FCF margin
7.3%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
-4.5%
Year over year
Net income growth YoY
Revenue (TTM)
$2.68B
Trailing 12 months
EPS growth YoY
Shares change YoY
+4.6%
Year over year · more shares
Revenue CAGR (3Y)
-1.4%
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
+46.1%
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-16.3%
Return on assets
-3.1%
Debt / equity
2.0
Current ratio
1.0
EBITDA (TTM)
$67.50M
Free cash flow (TTM)
$196.00M
Quick ratio
1.0
Interest coverage
Net debt / EBITDA
13.1
Return on invested capital
Trailing 12 months
Net cash
−$885.70M
Latest balance sheet
Cash & equivalents
$168.60M
Total assets
$2.71B
Total debt
$1.05B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$227.80M
Capital expenditures (TTM)
$31.80M
R&D (TTM)
SG&A (TTM)
$412.40M
Stock compensation (TTM)
$61.10M
R&D / revenue
Stock compensation / revenue
2.3%

Ownership (13F)

3 metrics
13F filers
336
13F filer change QoQ
+1
Institutional ownership
105.5%

Short interest

3 metrics
Short interest
12.1%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.28M
Insider-sentiment score
15 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1965040 CUSIP 34965K107 13F (30d) 215 filings 211 filers Visit website Investor relations